Tools

LEADER 02429nam 2200505 i 4500

001 on1416714496;

003 OCoLC;

005 20240430153541.0;

006 m o d f ;

007 cr |||||||||||;

008 240105s2023 dcua ob f000 0 eng c;

035 a| (Sirsi) o1416714496;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-23-105270;

088 a| GAO-23-105270;

245 10 a| Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters /c| United States Government Accountability Office.;

246 3 a| Medicare Part D: Centers for Medicare & Medicaid Services should monitor effects of rebates on plan formularies and beneficiary spending;

246 17 a| GAO-23-105270 Medicare Part D;

264 1 a| Washington, DC :b| United States Government Accountability Office,c| 2023.;

300 a| 1 online resource (iii, 59 pages) :b| color illustrations;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "September 2023.";

500 a| "GAO-23-105270.";

500 a| In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource; title from PDF title page (GAO, viewed January 5, 2024).;

610 20 a| Centers for Medicare & Medicaid Services (U.S.)v| Rules and practice.=| ^A503728;

650 0 a| Pharmaceutical services insurancez| United States.=| ^A11063;

650 0 a| Older peoplex| Pharmaceutical assistancez| United States.=| ^A1022988;

650 0 a| Medicare beneficiariesx| Government policyz| United States.=| ^A494453;

650 0 a| Rebatesz| United States.=| ^A566891;

856 40 u| https://purl.fdlp.gov/GPO/gpo2213827| 0;

922 a| BIBCONEWb| 20240105;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6312690;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6312690-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 2/22/2024x| EDOCUMENTz| JERESOURCE;

Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters / United States Government Accountability Office.

Author/creator	United States
Format	Electronic
Publication	Washington, DC : United States Government Accountability Office, 2023.
Description	1 online resource (iii, 59 pages) : color illustrations
Supplemental Content	https://purl.fdlp.gov/GPO/gpo221382
Subjects	Centers for Medicare & Medicaid Services (U.S.)--Rules and practice. Pharmaceutical services insurance--United States. Older people--Pharmaceutical assistance. --United States. Medicare beneficiaries--Government policy. --United States. Rebates--United States.

Variant title	Medicare Part D: Centers for Medicare & Medicaid Services should monitor effects of rebates on plan formularies and beneficiary spending
Running title	GAO-23-105270 Medicare Part D
General note	"September 2023."
General note	"GAO-23-105270."
General note	In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (GAO, viewed January 5, 2024).
Technical rpt number	GAO-23-105270
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-23-105270

Medicare Part D: CMS should monitor effects of rebates on plan formularies and beneficiary spending : report to congressional requesters / United States Government Accountability Office.

Click here for more information about this title